Increase of immunoglobulin A during ibrutinib therapy reduces infection rate in chronic lymphocytic leukemia patients

Hematol Oncol. 2021 Feb;39(1):141-144. doi: 10.1002/hon.2814. Epub 2020 Oct 22.
No abstract available

Keywords: IgA; ibrutinib; infections rate.

Publication types

  • Evaluation Study
  • Letter

MeSH terms

  • Adenine / administration & dosage
  • Adenine / analogs & derivatives*
  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoglobulin A / blood*
  • Infections* / blood
  • Infections* / mortality
  • Leukemia, Lymphocytic, Chronic, B-Cell* / blood
  • Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
  • Leukemia, Lymphocytic, Chronic, B-Cell* / mortality
  • Male
  • Middle Aged
  • Piperidines / administration & dosage*
  • Prospective Studies

Substances

  • Immunoglobulin A
  • Piperidines
  • ibrutinib
  • Adenine